Skip to content
eHealthTutorial — Research Peptide Reviews
FDA-approved prescription drug ingredient

GLP-1 receptor agonist clinical research

Dulaglutide

Dulaglutide is the active ingredient in FDA-approved Trulicity, supplied as a labeled single-dose solution in a pen. Approved-product findings do not validate an independently sourced research vial.

Explore the research
Generic research visual — not a commercial product
Compound typeLong-acting GLP-1 receptor agonist biologic
Evidence baseLarge controlled clinical trials and approved labeling
Regulatory contextFDA-approved in specific prescription products and indications
Page purposeResearch overview
Why there is no compound calculator on this page

FDA-approved dulaglutide products are supplied as labeled single-dose solutions in pens, not generic powder vials requiring user-directed reconstitution. A vial-and-syringe calculator here could imply equivalence of an independently sourced research product with the approved pen and its prescribed use; it would not be appropriate.

Research overview

What is Dulaglutide?

Dulaglutide is a long-acting glucagon-like peptide-1 receptor agonist used in an FDA-approved prescription product for specific labeled indications. It is a modified biologic molecule rather than an interchangeable generic “research peptide.” The product’s labeled formulation and delivery device are part of the approval context.

What has research examined?

The randomized, placebo-controlled REWIND trial included 9,901 adults with type 2 diabetes and cardiovascular risk factors or previous cardiovascular disease. Its prespecified composite of cardiovascular death, nonfatal heart attack, or nonfatal stroke occurred less often in the studied dulaglutide group than placebo. Approved labeling discusses its specific indications, risks, and single-dose pen strengths. Those data refer to the evaluated commercial product and cannot establish safety, quality, or equivalence for an affiliate seller’s vial.

Important limitation

A clinical outcome in a defined prescription-product study does not transfer to a differently sourced or prepared vial. Contraindications and warnings in the approved label matter; this page does not provide prescribing, preparation, or administration advice.

Research references

Calculation boundary

FDA-approved dulaglutide products are supplied as labeled single-dose solutions in pens, not generic powder vials requiring user-directed reconstitution. A vial-and-syringe calculator here could imply equivalence of an independently sourced research product with the approved pen and its prescribed use; it would not be appropriate.

For research purposes only. This page is educational and is not medical or veterinary advice or a recommendation to purchase, prepare, administer, or use any product.